Keyword search (3,448 papers available)


Candida albicans targets that potentially synergize with fluconazole.

Author(s): Lu H, Shrivastava M, Whiteway M, Jiang Y

Fluconazole has characteristics that make it widely used in the clinical treatment of C. albicans infections. However, fluconazole has only a fungistatic activity in C. albicans, therefore, in the long-term treatment of C. albicans infection with fluconazol...

Article GUID: 33587857
Title:Candida albicans targets that potentially synergize with fluconazole.
Authors:Lu H,  Shrivastava M,  Whiteway M,  Jiang Y
Link:https://www.ncbi.nlm.nih.gov/pubmed/33587857
DOI:10.1080/1040841X.2021.1884641
Category:Crit Rev Microbiol
PMID:33587857
Dept Affiliation: BIOLOGY
1 Department of Pharmacology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
2 Department of Biology, Concordia University, Montreal, QC, Canada.

Description:

Candida albicans targets that potentially synergize with fluconazole.

Crit Rev Microbiol. 2021 Feb 15; :1-15

Authors: Lu H, Shrivastava M, Whiteway M, Jiang Y

Abstract

Fluconazole has characteristics that make it widely used in the clinical treatment of C. albicans infections. However, fluconazole has only a fungistatic activity in C. albicans, therefore, in the long-term treatment of C. albicans infection with fluconazole, C. albicans has the potential to acquire fluconazole resistance. A promising approach to increase fluconazole's efficacy is identifying potential targets of drugs that can enhance the antifungal effect of fluconazole, or even make the drug fungicidal. In this review, we systematically provide a global overview of potential targets of drugs synergistic with fluconazole in C. albicans, identify new avenues for research on fluconazole potentiation, and highlight the promise of combinatorial strategies with fluconazole in combatting C. albicans infections.

PMID: 33587857 [PubMed - as supplied by publisher]